Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV6Z5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,360
Award facts
- Contract value 100% obligated
- $36,359.73 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $36,359.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections. This is a non-set-aside competitive award with an ultimate completion date of December 18, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that authorizes the company to supply comprehensive pharmaceutical products and medical supplies to support military and federal healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's IDC vehicle encompasses specialty medications, brand-name and generic pharmaceuticals, vaccines, and related medical supplies across multiple therapeutic domains. This delivery order for Zepbound, a diabetes and weight management medication, exemplifies the company's role in supplying specialized pharmaceutical products to support military healthcare programs. DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen among the strategic pharmaceutical suppliers supporting federal healthcare procurement.
Quick answers
Who was awarded contract SPE2DR26FV6Z5?
SPE2DR26FV6Z5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FV6Z5 worth?
The government has obligated $36,360 on SPE2DR26FV6Z5.
Is contract SPE2DR26FV6Z5 an order under another contract?
Yes. SPE2DR26FV6Z5 is a delivery order under SPE2DR25D2214, an indefinite delivery contract.
Was contract SPE2DR26FV6Z5 competed?
The extent of competition for SPE2DR26FV6Z5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award